Advertisement

Therapie

  • S. Ziegler
  • D. Nadal
  • H. W. Kreth
  • L. Schrod
  • M. H. Schöni
  • V. Wahn
  • G. Horneff
  • G. A. Holländer
  • U. Heinigner
  • R. Urbanek
  • A. Schuster
  • M. Götz
  • P. Birrer
  • J. H. Wildhaber
  • B. Oberwaldner
  • C.-P. Bauer
  • J. Innenmoser
  • W. Gruber
  • T. Nicolai
  • E. Eber
  • H. Hartmann
  • S. Fanconi
  • R. Burger
  • W. Kachel
  • T. Schaible
  • K. Paul
  • R. Hetzer
Chapter
  • 45 Downloads

Zusammenfassung

Zur Behandlung von Atemwegsinfektionen werden jährlich gewichtsmäßig enorme Mengen an antibakteriellen Substanzen, sog. Antibiotika, verbraucht. Viele dieser Therapien sind inadäquat, da die Mehrzahl der Infektionen viral ist. Selektive und durchdachte Anwendung von Antibiotika ist deshalb gefragt. Dazu sollten wichtige Entscheidungskriterien konsequent beachtet werden. Sie richten sich nach Mikroorganismus, Patient und Lokalisation der Infektion (Übersicht 3.1) sowie Therapiekosten.

Literatur

  1. Hoibi N, Ciofu O, Jensen T et al. (1996) Use of carbapenems and other antibiotics for pulmonary infections in patients with cystic fibrosis. Pediatr Infect Dis J 15:738–743Google Scholar
  2. Jacobs RF, Schutze GE, Young RA et al. (1997) Antimicrobial agents. In: Long SS, Pickering LK, Prober CG (eds) Practice and principles of pediatric infectious diseases. Churchill Livingstone, New York, pp 1606–1662Google Scholar
  3. Lebel MH, McCracken GH jr (1988) Aztreonam: Review of the clinical experience and potential uses in pediatrics. Pediatr Infect Dis J 7:331PubMedGoogle Scholar
  4. Mims CA, Playfair JHL, Roitt IM et al. (1993) Medical microbiology. Mos-by, St. Louis, pp 35.1–35.22Google Scholar
  5. Nelson JD (1996) Pocket book of pediatric antimicrobial therapy. Williams & Wilkins, BaltimoreGoogle Scholar
  6. O’Grady F, Lambert HP, Finch RG, Greenwood D (1997) Antibiotic and chemotherapy, 7th edn. Churchill Livingstone, New YorkGoogle Scholar
  7. Schaad UB (1992) Role of new quinolones in pediatric practice. Pediatr Infect Dis J 11:1043–1046PubMedGoogle Scholar
  8. Akademie für Kinderheilkunde und Jugendmedizin (1997) Empfehlungen zurTherapie und Prophylaxe von RSV-Infektionen im Krankenhaus. Kinderarzt 28:11–12Google Scholar
  9. American Academy of Pediatrics (1996) Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 97:137–140Google Scholar
  10. Crumpacker CS (1996) Ganciclovir. N Engl J Med 335:721–729PubMedGoogle Scholar
  11. Grose C, Wiedeman J (1997) Generic acyclovir vs. famciclovir and valacyclovir. Pediatr Infect Dis J 16:838–841PubMedGoogle Scholar
  12. Hayden FG (1996) Combination antiviral therapy for respiratory virus infections. Antivir Research 29:45–48Google Scholar
  13. Hayden FG, Osterhaus A, Treanor J et al. for the Influenza Study Group (1997) Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med 337:874–880PubMedGoogle Scholar
  14. Hitchcock MJM, Jaffe HS, Martin JC, Stagg RJ (1996) Cidofovir, a new agent with potent anti-herpesvirus activity. Antivir Chemistry Chemother 7:115–127Google Scholar
  15. Schiff GM, Sherwood JR (1999) Clinical activity of pleconaril in an experimentally inducex coxsackievirus A21 respiratory infection. J Infect Dis 181:20–26Google Scholar
  16. Tayaweera DT (1997) Minimising the dosage-limiting toxicities of fos-carnet induction therapy. Drug Safety 16:258–266Google Scholar
  17. Vilcek J, Sen GC (1996) Interferons and other cytokines. In: Fields BN, Knipe DM, Howley PM et al. (eds) Virology. Lippincott-Raven, PhiladelphiaGoogle Scholar
  18. Wagstaff AJ, Faulds D, Goa KL (1994) Aciclovir — A reappraisal of ist antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47:153–205PubMedGoogle Scholar
  19. Walther EK, Herberhold C (1993) Behandlung der laryngotrachealen Papillomatose mit kombinierter Anwendung von Laserchirurgie und intraläsionaler Applikation von Alpha-Interferon (Roferon ®). Laryngorhinootolologie 72:485–491Google Scholar
  20. Whitley RJ, Hayden FG, Reisinger KS et al. (2001) Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 20:127–133PubMedGoogle Scholar
  21. Agertoft L, Pedersen S (2000) Effect of long-term treatment with inhaled bidesonide on adult height in dchildren with asthma. N Engl J Med 343:1064–1070PubMedGoogle Scholar
  22. Barnes P J (1997) Inhaled glucocorticosteroids for asthma. N Engl J Med 332:868–875Google Scholar
  23. Brownlee KG (1997) A rational for the use of nebulized steroids in children. Eur Respir Rev 7:177–180Google Scholar
  24. Chung FK (1995) Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy. Eur Respir J8:1203–1213Google Scholar
  25. Hoag JE, McFadden ER jr (1991) Long term effect of chromolyn sodium on nonspecific bronchial hyperresponsiveness: A Review. Ann Allergy 66:53–63PubMedGoogle Scholar
  26. Holgate ST, Frew AJ (1997) Choosing therapy for childhood asthma. N Engl J Med 337:1690–1693PubMedGoogle Scholar
  27. Simons FER and the Canadian Beclomethasone Diproprionate Salmeterol Xinafoate Study Group (1997) A comparision of beclomethasone, salmeterol and placebo in children with asthma. N Engl J Med 337:1659–1666PubMedGoogle Scholar
  28. Sprecher A von, Beck A, Gerspacher M, Bray MA (1992) Pepti-doleukotriene antagonists, state of the art. Chimia 46:304–331Google Scholar
  29. Suissa S, Ernst P, Beanyoun S et al. (2000) Low-dose inhaled corticosteroids an the prevention of death from asthma. N Engl J Med 343: 332–336PubMedGoogle Scholar
  30. The Childhood asthma Management Program Research Group (2000) Long-term effect of Budesonide or nedocromil in children with asthma. N Engl J Med 343:1054–1063Google Scholar
  31. Toogood JH (1990) Complications of topical steroid therapy for asthma. Am Rev Respir Dis: 89–96Google Scholar
  32. Wildhaber JH, Dore ND, Wilson JM et al. (1999) Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 135:28–33PubMedGoogle Scholar
  33. Wildhaber JH, Monkhoff M, Sennhauser FH (2002) Dosage regimens for inhaled therapy in children should be reconsidered. J Peadiatr Child Health 38:115–116Google Scholar
  34. Cronstein BN (1996) Molecular therapeutics: Methotrexate and its mechanism of action. Arthritis Rheum 39:1951–1960PubMedGoogle Scholar
  35. Lynch JP, McCune WJ (1997) State of the art: immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 155:395–420PubMedGoogle Scholar
  36. Newton R (2000) Molecular mechanisms of glucocorticoid action: what ist important? Thorax 55:603–613PubMedGoogle Scholar
  37. L. Nghien et al. (2002) J Am Acad Dumatol 46:228Google Scholar
  38. Pauwels R (1986) Mode of action of corticosteroids in asthma and rhinitis. Clin Allergy 16:281–288PubMedGoogle Scholar
  39. Pedersen S, O’Byrne P (1997) A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 52 (Suppl 39): 1–34PubMedGoogle Scholar
  40. Tavadia SM, Mydlarski PR, Reis MD et al. (2000) Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case. J Am Acad Dermatol 42:628–632PubMedGoogle Scholar
  41. Weiß, Littman (1994) Cell 76:263PubMedGoogle Scholar
  42. Zisman DA, Lynch III JRToews GB et al. (2000) Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis. Chest 117:1619–162PubMedGoogle Scholar
  43. Butler JC, Breimann R, Campbell JF et al. (1993) Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1826–1831Google Scholar
  44. Cohn DL (1997) Use of the Bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine. Am J Med Sci 313:372–376PubMedGoogle Scholar
  45. Groothuis JR, Sinmoes EAF, Levine MJ et al. (1993) and the Respiratory Syncytial Virus Immune Globuline Study Group. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 329: 1524–1530PubMedGoogle Scholar
  46. Gruber WC, Campbell PW, Thompson JM et al. (1994) Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J Infect Dis 169:241–247PubMedGoogle Scholar
  47. Hall, CB (1994) Prospects for a respiratory syncytial virus vaccine. Science 265:1393–1394PubMedGoogle Scholar
  48. Jordens JZ, Slak MPE (1995) Haemophilus influenzae: Then and now. Eur J Clin Microbiol Infect Dis 14: 935–948PubMedGoogle Scholar
  49. Karron RA, Wright PF, Newman FK et al. (1995) A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis 172:445–450Google Scholar
  50. Lang AB, Schaad UB, Rüdeberg A et al. (1995) Effect of high affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J Pediatr 127:711–717PubMedGoogle Scholar
  51. Levine MM, Woodrow GC, Kaper JB, Cobon GS (1997) New generation vaccines, 2nd edn. Dekker, New York Basel HongkongGoogle Scholar
  52. Olin P, Rasmussen F, Gustafson L et al. (1997) for the ad hoc Group for the Study of Pertussis Vaccines. Randomized controlled trial of two-component, three component, and five component acellular pertussis vaccines compared with whole-cell vaccine. Lancet 350:1596–1577Google Scholar
  53. Pichler WJ (1996) Immunstimulantien bei chronischen Infekten. Schweiz Med Wochenschr 120:898–202Google Scholar
  54. Werner GH, Joliès P (1996) Immunostimulating agents: What next? Eur J Biochem 242:1–19PubMedGoogle Scholar
  55. Abramson MJ, Puy RM, Weiner J (2001) Allergen immunotherpy for asthma. Cochrane Database Syst Rev CD001186Google Scholar
  56. Bousquet J, Lockey RF, Mailing HJ (1998) WHO Position Paper: Allergen immunotherapy: therapeutic vaccines for allergic desease. Allergy 53 (Suppl):1–42Google Scholar
  57. Des Roches A, Paradis L, Menardo JL, Bouges S et al. (1997) Immunotherapy with a standardized dermatophagoides pteronys-sinus extract IV. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99:450–453PubMedGoogle Scholar
  58. Durham SR, Ying S, Varney VA et al. (1996) Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 97:1356–1365PubMedGoogle Scholar
  59. Ebner C, Siemann U, Bohle B et al. (1997) Immunological changes during specific immunotherapy of grass pollen allergy: reduced lym-phoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Ph 1 p 1, a major grass pollen allergen. Clin Exp Allergy 27:1007–1015PubMedGoogle Scholar
  60. Gruber W, Eber E, Zach M. (1997) Spezifische Immuntherapie bei Hausstaubmilben-allergischen Asthmapatienten. Monatsschr Kinderheilkd 145:144–154Google Scholar
  61. O’Hehir RE, Lamb JR (1992) Strategies for modulating immunoglobulin E synthesis. Clin Exp Allergy 22:7–10Google Scholar
  62. Peng Z, Naclerio RM, Norman PS, Adkinson NF jr (1992) Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol 89:519–529PubMedGoogle Scholar
  63. Moller C, Dreborg S, Ferdousi HA et al. (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109:251–256PubMedGoogle Scholar
  64. Rak S, Heinrich C, Jacobsen L et al. (2001) A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol 108:921–928PubMedGoogle Scholar
  65. Browne GJ, Penna AS, Phung X, Soo M (1997) Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 349:301–305PubMedGoogle Scholar
  66. Clarke JR, Aston H, Silverman M (1993) Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Child 69:125–129PubMedGoogle Scholar
  67. Crane J, Burgess C, Pearce N, Beasley R (1993) The ß-agonist controversy: a perspective. Eur Respir Rev 3:475–482Google Scholar
  68. Garcia-Marcos L, Schuster A, Cobos Barroso N (2003) Inhaled vortico-steroids plus long-acting ß2-agonists as combined therapy in asthma. Expert Opin Pharmacotherap 4:23–29Google Scholar
  69. Hendeles L, Weinberger M, Szefler S, Ellis E (1992) Safety and efficacy of theophylline in children with asthma. J Pediatr 120:177–183PubMedGoogle Scholar
  70. International Consensus Report on Diagnosis and Treatment of Asthma (1992) Publication 92–3091. National Institutes of Health, Bethesda, MDGoogle Scholar
  71. Kerem E, Levison H, Schuh S et al. (1993) Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 123:313–317PubMedGoogle Scholar
  72. Lenney W, Pedersen S, Boner AL et al. on behalf of an International Study Group (1995) Efficacy and safety of salmeterol in childhood asthma. Eur J Pediatr 154:983–990PubMedGoogle Scholar
  73. Menon K, Sutcliffe T, Klassen TP (1995) A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 126:1004–1007PubMedGoogle Scholar
  74. Osmond MH, Klassen M (1995) Efficacy of ipratropium bromide in acute childhood asthma. A meta-analysis. Acad Emerg Med 2: 651–656PubMedGoogle Scholar
  75. Pearce N, Beasley R, Crane J et al. (1995) End of the New Zealand asthma mortality epidemic. Lancet 345:41–44PubMedGoogle Scholar
  76. Szefler SJ, Bender BG, Jusko WJ et al. (1995) Evolving role of theophylline for treatment of chronic childhood asthma. J Pediatr 127:176–185PubMedGoogle Scholar
  77. Warner JO, Naspitz CK, Cropp GJA (1998) Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 25:1–17PubMedGoogle Scholar
  78. App EM (1996) Vergleichende Mukolytikatherapie. Pneumologie 50:845–853PubMedGoogle Scholar
  79. Corrao WM (1996) Chronic persistent cough: diagnosis and treatment update. Pediatr Ann 25:162–168PubMedGoogle Scholar
  80. Fuloria M, Rubin BK (2000) Evaluating the efficacy of mucoactive aerosol therapy. Respir Care 45:868–873PubMedGoogle Scholar
  81. Gillissen A, Bartling A, Schoen S, Schultze-Werninghaus G (1997) Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung 175:235–242PubMedGoogle Scholar
  82. Lester LA (1996) Mucolytic therapies. In: Leff AR (ed) Pulmonary and critical care pharmacology and therapeutics. McGraw-Hill, New York, pp 681–694Google Scholar
  83. Majima Y (2002) Mucoactive medications and airway disease. Pae-diatr Respir Rev 3:104Google Scholar
  84. Miyata T, Kai H,Lsohama Y, Takahama K (1998) Current opinion of mucoactive drug research: strategies and problems. Eur Respir J 11:480–491PubMedGoogle Scholar
  85. Robinson M, Hemming AL, Moriarty C et al. (2000) Effect of a short course of rhDNase on cough and mucocilary clearance in patients with cystic fibrosis. Pediatr Pulmonol 30:16–24PubMedGoogle Scholar
  86. Suri R, Grieve R, Normand C et al. (2002) Effects of Hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.Thorax 57:841–846PubMedGoogle Scholar
  87. Wills PJ, Cole PJ (1996) Mucolytic and mucokinetic therapy. Pulm Pharmacol 9:197–204PubMedGoogle Scholar
  88. Ziment I (2002) Herbal antitussives. Pulm Pharmacol Ther 15:327–333PubMedGoogle Scholar
  89. Ziment I (2000) Recent advances in alternative therapies. Curr Opin Pulm Med 6:71–78PubMedGoogle Scholar
  90. Davis WB, Pacht ER (1997) Extracellular antioxidant defenses. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2271–2278Google Scholar
  91. Halliwell B (1994) Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 344: 721–724PubMedGoogle Scholar
  92. Henson PM, Johnston RB (1987) Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest 79: 669–674PubMedGoogle Scholar
  93. Lucey EC, Stone PJ, Snider GL (1997) Consequences of proteolytic injury. In: Crystal RG, West J B, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2237–2250Google Scholar
  94. McElvaney NG, Crystal RG (1997) Proteases and lung injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2205–2218Google Scholar
  95. McElvaney NG, Crystal RG (1997) Antiproteases and lung defense. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2219–2235Google Scholar
  96. McElvaney NG, Birrer P, Chang-Stroman L, Crystal RG (1992) Neutrophils, neutrophil elastase and the fragile lung: the pathogenesis and therapeutic strategies relating to lung derangements in the common hereditary lung disorders. In: Grassi C, Travis J, Casali L, Luisetti M (eds) Biochemistry of pulmonary emphysema. Springer, Berlin Heidelberg New York Tokyo, pp 169–187Google Scholar
  97. Repine JE, Heffner JE (1997) Lung antioxidants. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2259–2269Google Scholar
  98. Schraufstätter IL), Cochrane CG (1997) Oxidants: Types, sources and mechanisms of injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2251–2258Google Scholar
  99. Warren JS, Ward PA (1997) Consequences of oxidant injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2279–2288Google Scholar
  100. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365–376PubMedGoogle Scholar
  101. Hickey AJ (ed) (1996) Inhalation aerosols: physical and biological basis for therapy. Marcel Dekker, New YorkGoogle Scholar
  102. Moren F, Dolovich MB, Newhouse MT, Newman SP (eds) (1993) Aerosols in medicine: principles, diagnosis and therapy. Elsevier, AmsterdamGoogle Scholar
  103. Zach M (1996) Pädiatrische Inhalationstherapie. Pädiatr Praxis 51:671–684Google Scholar
  104. Davies H, Helms P, Gordon J (1992) Effect of posture on regional ventilation in children. Pediatr Pulmonol 12:227–232PubMedGoogle Scholar
  105. Hardy KA (1994) A review of airway clearance: new techniques, indications, and recommendations. Respir Care 39:440–452Google Scholar
  106. Mahlmeister MJ, Fink JB, Hoffmann GL, Fifer LF (1991) Positive-expiratory-pressure mask therapy: theoretical and practical considerations and a review of the literature. Respir Care 36: 1218–1229Google Scholar
  107. Mellins RS (1974) Pulmonary physiotherapy in the pediatric age group. Am Rev Respir Dis 110:137–142PubMedGoogle Scholar
  108. Menkes H, Britt J (1980) Rationale for physical therapy. Am Rev Respir Dis 122 (Suppl 2): 127–131PubMedGoogle Scholar
  109. Pryor JA (ed) (1991) Respiratory care. In: International perspectives in physical therapy, 1 st edn. Churchill Livingstone, EdinburghGoogle Scholar
  110. Webber BA (1980) Evaluation and inflation in respiratory care. Physiotherapy 77:801–804Google Scholar
  111. Webber BA, Pryor JA (eds) (1993) Physiotherapy for respiratory and cardiac problems, 1 st edn. Churchill Livingstone, EdinburghGoogle Scholar
  112. Zach MS, Oberwaldner B (1999) Chest physiotherapy. In: Taussig L, Landau L (eds) Textbook of pediatric respiratory medicine. Mosby, St. Louis, pp 299–311Google Scholar
  113. Zach M, Oberwaldner B, Purrer B et al. (1981) Thoraxphysiothera-peutische Behandlung bronchopulmonaler Erkrankungen des Kindesalters. Monatsschr Kinderheilkd 129:633–636PubMedGoogle Scholar
  114. Baror O (1986) Die Praxis der Sportmedizin in der Kinderheilkunde. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  115. Bauer CP van Egmond A, Eckl F et al. (1996) Kinderrehabilitation bei Asthma bronchiale. Kinderarzt 1093–1100Google Scholar
  116. Biberger A (1990) Die motorischen Hauptbeanspruchungsformen und ihre Anwendung im Sport bei Asthma bronchiale. In: Lecheler J, Fischer J (Hrsg) Bewegung und Sport bei Asthma bronchiale. Echo, Köln, S 55–61Google Scholar
  117. Egmond-Fröhlich A van, Haag C, Eckl F, Bauer CP (1997) Qualitätssicherung in der stationären Rehabilitation von Kindern und Jugendlichen mit Asthma bronchiale. Monatsschr Kinderheilkd 145:328Google Scholar
  118. Ehrenberg H (1987) Krankengymnastische Atemtherapie beim Asthma bronchiale im Kindes- und Jugendalter. Atemwegs Lun-genkrankh 13:18–22Google Scholar
  119. Innenmoser J (1992) Die Bedeutung von Bewegung, Spiel, Sport und Sporttherapie für in der während stationärer Rehabilitationsmaßnahmen in Fachkliniken. Z Krankengymnastik 44:302–320 (Sonderdruck)Google Scholar
  120. Innenmoser J, Darlath W (1990) Rolle und Funktion des Sporttherapeutischen Teams in der Prävention und Rehabilitation von Asthmatikern. Präv Rehab 2:109–114Google Scholar
  121. Lecheler J, Pfannebecker B, Biberger A et al. (1997) Asthma und Sport bei Kindern und Jugendlichen — Neue Erkenntnisse. Monatsschr Kinderheilkd 145:319Google Scholar
  122. Oseid S (1983) Physical activity as part of comprehensive rehabilitation programme in asthmatic children. In: Oseid S, Edwards AM (eds) The asthmatic child in play and sports. Wudon Pitman, London, pp 237–258Google Scholar
  123. Petermann F, Walther HJ, Kühl C, Biberger A (1993) Sport und Atemtherapie. In: Petermann F, Walther HJ, Köhl C, Biberger A (Hrsg) Asthma-Verhaltenstraining mit Kindern und Jugendlichen. Quintessenz, S 71–74Google Scholar
  124. Bettschart R, Glaeske G, Langbein K, Salier R, Skalnik C (1995) Bittere Naturmedizin. Wirkung und Bewertung der alternativen Behandlungsmethoden, Diagnoseverfahren und Arzneimittel. Kiepenheuer & Witsch, KölnGoogle Scholar
  125. Ernst E, Harkness E (2001) Spinal manipulation: A systemic review of sham-controlled, double-blind, randomized clinical trials. J Pain Symptom Manage 24:879–889Google Scholar
  126. Gruber W, Eber E, Zach M (1997) Alternativmedizin und Asthma bronchiale. Monatsschr Kinderheilkd 145:786–796Google Scholar
  127. Gruber W, Eber E, Malle-Scheid D, Pfleger A, Weinhandl E, Dorfer L, Zach MS (2002) Laser acupuncture in children and adolescents with exercise induced asthma.Thorax 57:222–225PubMedGoogle Scholar
  128. Kleijnen J, Rietter G, Knipschild P (1991) Acupuncture and asthma: a review of controlled trials. Thorax 46:799–802PubMedGoogle Scholar
  129. Lewith GT, Watkins AD (1996) Unconventional therapies in asthma: an overview. Allergy 51:761–769PubMedGoogle Scholar
  130. Linde K, Jobst K, Panton J (2002) Acupuncture for chronic asthma (Cochrane Review). In: Cochrane Library, Issue 2. Update Software, OxfordGoogle Scholar
  131. Linde K, Jobst KA (2002) Homeopathy for chronic asthma (Cochrane Review). In: Cochrane Library, Issue 2. Update Software, OxfordGoogle Scholar
  132. Bhende MS, Thompson AE (1995) Evaluation of an end-tidal CO2 detector during pediatric cardiopulmonary resuscitation. Pediatrics 95:395–399PubMedGoogle Scholar
  133. Bush CM, Jones JS, Cohle SD, Johnson H (1996) Pediatric injuries from cardiopulmonary resuscitation. Ann Emerg Med 28:40–44PubMedGoogle Scholar
  134. Gnauck K, Lungo JB, Scalzo A et al. (1994) Emergency intubation of the pediatric medical patient: use of anesthetic agents in the emergency department. Ann Emerg Med 23:1242–1247PubMedGoogle Scholar
  135. Orlowski JA (1994) Emergency alternatives to intravenous access. Pediatr Clin North Am 41:1183–1199PubMedGoogle Scholar
  136. Pediatric Basic Life Support (2000) Circulation 102 (Suppl I): 253–290Google Scholar
  137. Pediatric Advanced Live Support (2000) Circulation 102 (Suppl I): 291–342Google Scholar
  138. Rosenzweig EB, Stare TJ, Chen JM et al. (1999) Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 100 (Suppl II): 182–186Google Scholar
  139. Schindler MB, Bohn D, Cox PN et al. (1996) Outcome of out of hospital cardiac or respiratory arrest in children. N Engl J Med 335: 1473–1479PubMedGoogle Scholar
  140. Ummenhofer W, Frei FJ, Urwyler A, Drewe J (1994) Are laboratory values in bone marrow aspirate predictable for venous blood in pediatric patients? Resuscitation 27:123–128PubMedGoogle Scholar
  141. Ushay HM, Notterman DA (1997) Pharmacology of pediatric resuscitation. Pediatr Clin North Am 44:207–233PubMedGoogle Scholar
  142. Lusk RP, Woolley AL, Holinger LD (1997) Laryngotracheal stenosis. In: Holinger LD, Lusk RP, Green CG (eds) Pediatric laryngology and bronchoesophagology. Lippincott-Raven, Philadephia New York, pp 165–186Google Scholar
  143. O’Connor DM (1995) Developmental anatomy of the larynx and trachea. In: Myer CM III, Cotton RT, Shott SR (eds)The pediatric airway. Lippincott, Philadelphia, pp 1–14Google Scholar
  144. Kissoon N, Singh N (1993) Airway management and ventilatory support. In: Reisdorff EJ, Roberts MR, Wiegenstein JG (eds) Pediatric emergency medicine. Saunders, Philadelphia, pp 51–67Google Scholar
  145. Bach JR (1995) Indications for tracheostomy and decannulation of tra-cheostomized ventilator users. Monaldi Arch Chest Dis 3:223–227Google Scholar
  146. Crysdale WS, Feldman RI, Naito K (1988) Tracheotomies: a 10-year experience in 319 children. Ann Otol Rhinol Laryngol 97: 439–443PubMedGoogle Scholar
  147. Fitton CM, Myer CM III (1995) Home care of the child with a tracheotomy. In: Myer CM III, Cotton RT, Shott SR (eds) The pediatric airway — an interdisciplinary approach. Lippincott, Philadelphia, pp 171–179Google Scholar
  148. Oberwaldner B, Zobel G, Zach M (1992) Pädiatrische Tracheo-stomapflege. Monatsschr Kinderheilkd 140:205–215Google Scholar
  149. Sherman JM, Davis S, Albamonte-Petrick S et al. (2000) Care of the child with a chronic tracheostomy. Am J Respir Crit Care Med 161: 297–308PubMedGoogle Scholar
  150. Shott SR (1995) Pediatric Tracheostomy. In: Myer CM III, Cotton RT, Shott SR (eds) The pediatric airway — an interdisciplinary approach. Lippincott, Philadelphia, pp 151–169Google Scholar
  151. Fauroux B, Sardt A, Foret D (1995) Home treatment for chronic respiratory failure in children: a prospective study. Eur Respir J 8:2062–2066PubMedGoogle Scholar
  152. Fichter J (1995) Methoden der nichtinvasiven Beatmung bei respiratorischer Insuffizienz. Med Klin 90:4–6Google Scholar
  153. Hartmann H, Samuels MP, Noyes JP, Southall DP (1997) Negative ex-trathoracic pressure ventilation in infants and young children with central hypoventilation syndrome. Pediatr Pneumol 23: 155–157Google Scholar
  154. Köhler D, Criée CP, Raschke F (1997) Leitlinien zur häuslichen Sauerstoff- und Heimbeatmungstherapie. Med Klin 92:2–6Google Scholar
  155. Moers A von, Müller-Pawlowski H, Michael T, Scheffner D (1994) BIPAP-(Bilevel positive airway pressure-)Therapie bei Kindern und Jugendlichen mit neuromuskulären Erkrankungen. Med Klin 89:26–29Google Scholar
  156. Noyes J, Hartmann H, Samuels M, Southall D (1999) The experiences and views of parents who care for ventilator-dependent children. J Clin Nurs 8:440–450PubMedGoogle Scholar
  157. Paditz E (1994) Nächtliche nasale Maskenbeatmung im Kindesalter. Pneumologie 48:744–749PubMedGoogle Scholar
  158. Poets CF (1996) Ambulante Sauerstofftherapie. Monatsschr Kinder-heilkd 144:1198–1205Google Scholar
  159. Ragette R, Mellies W, Schwake C et al. (2002) Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 57:724–728PubMedGoogle Scholar
  160. Weese-Mayer DE (1997) Diaphragmatic pacing by electrical stimulation of the phrenic nerve: 1996 update. Pediatr Pneumol 23:157–159Google Scholar
  161. Abman SH, Greibel J, Parker D et al. (1994) Acute effects of iNO in children with severe acute hypoxemic respiratory failure. J Pediatr 124:881–888PubMedGoogle Scholar
  162. Clark RH (1994) High-frequency ventilation. J Pediatrie 124:661–670Google Scholar
  163. Clark RH, Gerstmann DR, Null DM jr, DeLemos RA (1992) Prospective randomized comparison of high frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 89:5–12PubMedGoogle Scholar
  164. Fretschner R, Laubscher TP, Brunner JX (1996) New aspects of pulmonary mechanics: slowly distensible compartments of the respiratory system, identified by a PEEP step maneuver. Intensive Care Med 22:1328–1334PubMedGoogle Scholar
  165. Gattinoni L, D’Andréa L, Peloši P et al. (1993) Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA 269:2122–2127PubMedGoogle Scholar
  166. Hickling KG, Henderson SJ, Jackson R (1990) Low mortality associated with low volume pressure limited ventilation with permissive hy-percapnia in severe adult respiratory distress syndrome. Intensive Care Med 16:372–377PubMedGoogle Scholar
  167. Hirschl RB, Pranikoff T, Schreiner RJ et al. (1995) Liquid ventilation in adults, children, and full-term neonates. Lancet 346: 1201–1202PubMedGoogle Scholar
  168. Kolobow T, Moretti MP, Fumagalli R et al. (1987) Severe impairment in lung function induced by high airway pressure during mechanical ventilation. Am Rev Respir Dis 135:312–315PubMedGoogle Scholar
  169. Lamm WJ, Graham MM, Albert RK (1994) Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 150:184–193PubMedGoogle Scholar
  170. Maclntyre NR (1996) New modes of mechanical ventilation. Clin Chest Med 17:411–421Google Scholar
  171. Muscedere JG, Mullen JBM, Gan K, Slutsky AS (1994) Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 149:1327–1334PubMedGoogle Scholar
  172. Pappert D, Rossaint R, Slama K et al. (1994) Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome. Chest 106:1511–1516PubMedGoogle Scholar
  173. Ranieri VM, Giuliani R, FioreT et al. (1994) Volume-pressure curve of the respiratory system predicts effects of PEEP in ARDS. Am J Respir Crit Care Med 149:19–27PubMedGoogle Scholar
  174. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399–405PubMedGoogle Scholar
  175. Weis CM, Wolfson MR, Shaffer TH (1997) Liquid-assisted ventilation: Physiology and clinical application. Ann Med 29:509–517PubMedGoogle Scholar
  176. Wilson JM, Bower LK, Thompson JE et al. (1996) ECMO in evolution:The impact of changing patient demographics and alternative therapies in ECMO. J Pediatr Surg 31:1116–1123PubMedGoogle Scholar
  177. Bartlett RH, Gazzangia AB, Jefferies MR et al. (1976) Extracorporeal membrane oxygenation (ECMO) for cardiopulonary support in infancy. Trans Am Soc Artif Org 22:80–93Google Scholar
  178. Field D, Davies C, Elbourne D et al. (1996) UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 348:75–82Google Scholar
  179. Kachel W, Arnold D, Rettwitz W et al. (1987) Extrakorporale Membra-noxygenierung für Neugeborene mit schwerer Atemstörung. Monatsschr Kinderheilkd 135:735–741PubMedGoogle Scholar
  180. Kachel W, Arnold D (Hrsg) Extrakorporale Membranoxygenierung beim Neugeborenen. Thieme, Stuttgart New YorkGoogle Scholar
  181. Kachel W, Varnholt V, Lasch P et al. (1995) High frequency oscillatory ventilation and nitric oxide; alternative or complementary to ECMO. IntJ Artif Org 10:589–597Google Scholar
  182. Liedgens P, Kachel W, Varnholt V et al. (1995) Extrakorporale Membranoxygenierung mit venovenöser Doppellumentechnik. Monatsschr Kinderheilkd 143: 375–378Google Scholar
  183. Müller W, Kachel W, Kuntz S et al. (1995) Die Behandlung der persistierenden pulmonalen Hypertension des Neugeborenen (PPHN) durch Stickoxidinhalation. Monatsschr Kinderheilkd 143:466–474Google Scholar
  184. Aurora P, Whitehead B, Eade A, Bowyer J, Whitmore P, Rees PG, Tsang VT et al. (1999) Lung transplantation and life extension in children with cystic fibrosis. Lancet 354:1591–1593PubMedGoogle Scholar
  185. Aurora P, Wade A, Whitmore P, Whitehead B (2000) A model for predicting life expectancy of children with cystic fibrosis. Eur Respir J 16:1056–1060PubMedGoogle Scholar
  186. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Mohacsi PJ, Hertz ML (2002) The registry of the International Society for Heart and Lung Transplantation: Fifth official pediatric report-2001–2002. J Heart Lung Transplant 21 (8):827PubMedGoogle Scholar
  187. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB (2002) Bronchiolitis obliterans syndrome 2001: An Update of the diagnostik criteria. J Heart Lung Transplant 21:297–310PubMedGoogle Scholar
  188. Hertz ML, Taylor DO, Trulock EP, Boucek MM, Mohacsi PF, Edwards LB, Keck BM (2002) The registry of the International Society for Heart and Lung Transplantation: Nineteenth official report — 2002. J Heart Lung Transplant 21:950–970PubMedGoogle Scholar
  189. Hosenpud JK, Bennett LE, Keck BM, Boucek MM, Novick RJ (2001) The registry of the International Society for Heart and Lung Transplantation: Eighteenth official report — 2001. J Heart Lung Transplant 20:805–815PubMedGoogle Scholar
  190. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC (2001) Suvival effect of lung transplantation among patients with cystic fibrosis. JAMA 286:2683–2689PubMedGoogle Scholar
  191. Noyes BE, Kurland G, Orenstein DM (1997) Lung and Heart-Lung Transplantation in Children. Pediatric Pulmonol 23:39–48Google Scholar
  192. Paul K, Hetzer R (2001) Lungentransplantation. In: Reinhardt D, Götz M, Kraemer R, Schöni M (Hrsg) Cystische Fibrose. Springer Berlin, Heidelberg, New York, TokyoGoogle Scholar
  193. Reichenspurner H, Girgis RE, Robbins RC et al. (1995) Obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 60:1845–53PubMedGoogle Scholar
  194. Sundaresan RS (1995) Lung transplantation. In: Makowka L, Sher L (eds) Handbook of organ transplantation. Landes, Austin, pp 133–171Google Scholar
  195. Starnes V, Barr ML, Cohen RG, Hagen JA, Wells WJ, Horn M, Schenkel FA (1996) Living-donor lobar lung transplantation experience: intermediate results. J Thorac Cardiovasc Surg 112(5): 1284–1290PubMedGoogle Scholar
  196. Trulock EP (1997) Lung transplantation. Am J Respir Crit Care Med 155(3): 789–818PubMedGoogle Scholar
  197. Yankaskas JR, Mallory GB (1998) Lung transplantation in cystic fibrosis. Consensus Conference Statement. Chest 113 (1): 217–226PubMedGoogle Scholar
  198. Yousem SA, Berry GJ, Cagle PT et al. (1996) Revision of the 1990 Working Formulation for the classification of pulmonary allograft tejection: Lung Rejection Study Group. J Heart Lung Transplant 15:1–15PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • S. Ziegler
  • D. Nadal
  • H. W. Kreth
  • L. Schrod
  • M. H. Schöni
  • V. Wahn
  • G. Horneff
  • G. A. Holländer
  • U. Heinigner
  • R. Urbanek
  • A. Schuster
  • M. Götz
  • P. Birrer
  • J. H. Wildhaber
  • B. Oberwaldner
  • C.-P. Bauer
  • J. Innenmoser
  • W. Gruber
  • T. Nicolai
  • E. Eber
  • H. Hartmann
  • S. Fanconi
  • R. Burger
  • W. Kachel
  • T. Schaible
  • K. Paul
  • R. Hetzer

There are no affiliations available

Personalised recommendations